Results 191 to 200 of about 1,044,094 (254)

Characterising a New Cannabis Trend: Extensive Analysis of Semi-Synthetic Cannabinoid-Containing Seizures From Germany. [PDF]

Drug Test Anal
Hundertmark M, Besch L, Röhrich J, Germerott T, Wunder C.   +4 more
europepmc   +1 more source

Conceptualizing the relationship between synthetic cannabinoid use and neuroleptic malignant syndrome. [PDF]

Bipolar Disord
Zhang V, Wirtz AJ, Dhingra A, Zahid A, Hussain N.   +4 more
europepmc   +1 more source

The resurgence of synthetic cannabinoid receptor agonists as adulterants in the Era of Cannabis legalization: Lessons from prior epidemics and clinical implications. [PDF]

Neurosci Biobehav Rev
Jones AT, Marwan Abu Taha A, Miller GP.
europepmc   +1 more source

In vivo assessment of the nephrotoxic effects of the synthetic cannabinoid AB-FUBINACA. [PDF]

Forensic Toxicol
Alzu'bi A, Abu-El-Rub E, Al-Trad B, Alzoubi H, Abu-El-Rub H, Albals D, Abdelhady GT, Bader NS, Almazari R, Al-Zoubi RM.   +9 more
europepmc   +1 more source

Synthetic cannabinoid receptor agonists exacerbate fentanyl-elicited respiratory depression and confer resistance to naloxone rescue in mice. [PDF]

Drug Alcohol Depend
James JC, Thrush JR, Yusufali TM, Shaw HE, Avram M, Moran JH, Fantegrossi WE.   +6 more
europepmc   +1 more source

The rise of so-called adolescent "zombie" behavior: a spotlight on synthetic cannabinoid abuse. [PDF]

Braz J Psychiatry
Mendonça-Ferreira P, Bombana H, Castaldelli-Maia JM.   +2 more
europepmc   +1 more source

Tail-less precursors in synthetic cannabinoid production: investigating a clandestine laboratory, seized samples, and CB₁ activity. [PDF]

Arch Toxicol
Monti MC, Rautio T, Deventer MH, Schläpfer M, Tveit J, Krotulski AJ, Marland V, Reid R, Daeid NN, McKenzie C, Stove CP, Green H, Norman C.   +12 more
europepmc   +1 more source

Structure-metabolism relationships of 4-pentenyl synthetic cannabinoid receptor agonists using in vitro human hepatocyte incubations and high-resolution mass spectrometry. [PDF]

Arch Toxicol
Baginski SR, Lindbom K, Valencia Crespo B, Bessa G, Rautio T, Wu X, Dahlén J, Nisbet LA, McKenzie C, Gréen H.   +9 more
europepmc   +1 more source

Reelin Deficiency and Synaptic Impairment in the Adolescent Prefrontal Cortex Following Initial Synthetic Cannabinoid Exposure. [PDF]

Biol Psychiatry Glob Open Sci
Silva-Hurtado TJ, Giua G, Lassalle O, Makrini-Maleville L, Strauss B, Wager-Miller J, Freyermuth JM, Mackie K, Valjent E, Manzoni OJJ, Chavis P.   +10 more
europepmc   +1 more source

Identification and Investigation of the Intrinsic Receptor Activation Potential and Metabolization of the New Oxo-Pyridyl Synthetic Cannabinoid Receptor Agonist CH-FUBBMPDORA. [PDF]

Drug Test Anal
Deventer MH, Emanuele MC, Stang BN, Van Uytfanghe K, Masson J, Bouvot X, Lamoureux C, Proposito A, Reniero F, Holland MV, Krotulski AJ, Mannina L, Stove CP, Guillou C.   +13 more
europepmc   +1 more source